GSK Partners with Zhifei to Boost Shingrix® in China
By Shweta Gupta
Pharma Deals Review: Vol 2023 Issue 10 (Table of Contents)
Published: 25 Oct-2023
DOI: 10.3833/pdr.v2023.i10.2825 ISSN: 1756-7874
Section: Distribution & Marketing
Fulltext:
Abstract
GSK has entered into an exclusive agreement with Chongqing Zhifei Biological Products to co-promote GSK’s herpes zoster vaccine, Shingrix®, for shingles in China...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018